Clinical effects of a 3-month formulation LH-RH agonist (Zoladex LA 10.8 mg depot) in patients with prostate cancer
Pharmacodynamics (PD), anti-tumor effects, safety and pharmacokinetics of a 3-month formulation of goserelin (Zoladex LA 10.8 mg depot: "10.8 mg depot") were investigated in a collaborative multicenter study. Study participants were 40 Japanese patients with prostate cancer comprising 20 u...
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 47(2001), 5 vom: 09. Mai, Seite 349-61 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , , , |
| Format: | Aufsatz |
| Sprache: | Japanese |
| Veröffentlicht: |
2001
|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica |
| Schlagworte: | Clinical Trial English Abstract Journal Article Multicenter Study Antineoplastic Agents, Hormonal Delayed-Action Preparations Goserelin 0F65R8P09N Gonadotropin-Releasing Hormone 33515-09-2 mehr... |